REMINDER: Our user survey closes TODAY, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPURE.L Regulatory News (PURE)

  • There is currently no data for PURE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

PRECLOSE PERIOD UPDATE FY 2015

6 Jul 2015 07:00

RNS Number : 2068S
PureCircle Limited
06 July 2015
 



PURECIRCLE LIMITED

("PureCircle" or the "Company")

 

PRECLOSE PERIOD UPDATE FY 2015

 

PureCircle (LSE: PURE) the world's largest producer and marketer of high purity stevia today provides a trading update in respect of its financial year to 30 June 2015 (FY2015). The Company's results for the full year FY2015 will be announced on Monday 21 September 2015.

Sales

Sales in the second half FY2015 (2H FY2015) are expected to be US$84 million giving not less than US$127 million for the full year FY2015, an increase of 26% against FY2014 sales of US$101 million.

FY2015 sales have been adversely impacted by the weakening of certain sales' currencies (eg Mexican Peso, Euro) relative to the US$. On a constant FY2014 US$ exchange rate basis, FY2015 sales would have increased 31% to US$ 132 million.

In FY2015 there has been growth in sales across all geographic regions driven by accelerating market adoption of stevia, enabled by our range of proprietary ingredients and customizable ingredient combinations. Mintel has reported 627 new products launched using stevia in the quarter to 31 March 2015, which represents a 28% increase over the number launched in the same quarter in 2014. PureCircle continues to lead the growth of this market and our project pipeline gives us confidence that future sales growth at these rates is sustainable.

Margins

As noted in our 16 March 2015 Interim results statement, there has been a tightening of leaf supply in China which will impact our FY2015 margins adversely. The company is actively addressing this with increased investments in South America and Africa leaf development to better balance its future leaf supply.

In addition our FY2015 gross margin has been reduced by foreign exchange. The US$5 million sales impact was only partly offset by weaker cost of sales currencies giving a net US$3 million adverse gross margin impact.

Despite this, we expect the FY2015 growth in sales volumes and revenues to result in gross margin 9%, EBITDA 16% and net profit 73% higher than FY2014 comparatives at US$40 million, US$25 million and US$4 million respectively.

Cashflow and net debt

The Group expects to end FY2015 with net debt of US$53 million (FY2014 US$80 million) and cash and funding headroom of US$82 million (FY2014 US$66million).

Commenting on the FY2015 trading update, PureCircle CEO Magomet Malsagov said:

In FY2015 the global stevia market has again grown with more than 6,500 products across all categories now launched using stevia ingredients, mainly enabled by PureCircle's innovative product portfolio. The size and range of products now in market and of customers using stevia as a core part of their ingredient mix gives us confidence in the increased future demand for PureCircle stevia ingredients. Accordingly in FY2015 we kicked off expansion in our production capacity, which is due to come on stream in FY2017.

Our company and the business are at a stage of evolution where critical mass and top-line growth is important. We are pleased that in FY 2015 the Company maintained momentum and delivered yet another year of strong sales growth and despite challenges firmly established our business in profitable territory. Our entire range of proprietary ingredients and customizable ingredient combinations contributed to that growth. With increased investments in leaf diversification we expect leaf costs to normalize over time. Further, this diversification will also help our foreign exchange exposures.

Stevia products are still in the roll-out phase in many important markets and until market consumption smooths out, growth will come with a lumpy sales profile and therefore some volatility: this adds some complexity to our ability to provide guidance in the short term. However we are confident of the Company's future prospects and of continued long term sales growth and profitability."

 

 

Enquiries:

PureCircle Limited (www.purecircle.com)

Magomet Malsagov, CEO

+603 2166 2066

William Mitchell, CFO

+44 7974 005 163

RFC Ambrian Ltd (NOMAD)

+61 8 9480 2500

Stephen Allen

 

NOTES TO EDITORS

PureCircle is the global leader in production and marketing of high purity stevia ingredients. PureCircle leads the industry with development of a vertically integrated, sustainable and natural supply chain. Stevia is grown for PureCircle across South America, Africa, Asia and the United States where it provides a sustainable cash crop for farming communities. As part of the company's proprietary Stevia 3.0 TM portfolio, PureCircle has developed a broad range of ingredient solutions and has pioneered such ingredients as Reb A, SG95, and breakthrough ingredients such as PureCircle Alpha, Reb D, Reb M as well as PureCircle Flavors. PureCircle also established joint venture partnerships with sugar industry leaders to innovatively combine stevia and sugar for natural sweetening solutions and locally support customers. These global partnerships include Tereos PureCircle Solutions, with Tereos and NPSweet A/S with Nordzucker, in Europe. As part of its industry leadership, PureCircle pioneered the trust mark Stevia PureCircle®, which educates consumers about the benefits of stevia and provides a strong base of trust for both consumers and food and beverage companies alike. The company also founded The Global Stevia Institute, (www.globalsteviainstitute.com ) the leading resource for accurate, science-based information on stevia led by a global advisory board of internationally recognized health professionals. PureCircle's global headquarters are in Kuala Lumpur, Malaysia. PureCircle is listed on the London Stock Exchange AiM market under the ticker symbol: PURE. For more information on PureCircle, visit: www.purecircle.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUGUBPMUPAUPQ
Date   Source Headline
1st Jul 20205:10 pmRNSScheme of Arrangement becomes Effective
30th Jun 20206:00 pmRNSNew External Auditor Appointment
29th Jun 20205:45 pmRNSChanges in the Board Composition
26th Jun 20206:37 pmRNSCourt sanction of the Scheme
18th Jun 20205:47 pmRNSResults of Court Meeting and General Meeting
18th May 20205:45 pmRNSPublication of Scheme Document
7th May 20209:37 amRNSResults of Adjourned 2019 Annual General Meeting
7th May 20207:00 amRNSDispatch Date for Scheme Document
5th May 20202:31 pmRNSPDMR Notification
1st May 20207:00 amRNSBlock Listing Application
29th Apr 20207:00 amRNSNew Banking Facility
28th Apr 20203:22 pmRNSUpdate on Adjourned 2019 Annual General Meeting
20th Apr 20209:04 amRNSForm 8.3 - PureCircle Limited
20th Apr 20208:50 amRNSForm 8.3 - PureCircle Limited
20th Apr 20208:32 amRNSForm 8 (OPD) (PureCircle Limited)
16th Apr 20203:54 pmRNSForm 8.3 - PureCircle Limited
16th Apr 20203:08 pmRNSForm 8 (OPD) (PureCircle Limited)
16th Apr 20202:43 pmRNSForm 8.3 - PureCircle Limited
16th Apr 20202:40 pmRNSForm 8.3 - PureCircle Limited
16th Apr 20202:35 pmRNSForm 8.3 - PureCircle Limited
16th Apr 20202:30 pmRNSForm 8.3 - PureCircle Limited
15th Apr 20207:30 amRNSRestoration PureCircle Limited
9th Apr 20204:52 pmRNSNotice of Adjourned AGM and Annual Report
9th Apr 20202:07 pmRNSOffer for PureCircle Limited
9th Apr 20201:56 pmRNSUnaudited Interim Results and Trading Update
5th Mar 20207:00 amRNSCompany Update
5th Mar 20207:00 amRNSManagement Changes
19th Feb 20207:00 amRNSUpdate on lending facilities
10th Feb 20201:25 pmRNSResults of AGM and Directorate Change
4th Feb 20202:46 pmRNSCFO appointment effective
28th Jan 20203:45 pmRNSManagement Update
14th Jan 20204:42 pmRNSNotice of AGM and Company Update
3rd Jan 20202:00 pmRNSAppointment of CFO
2nd Jan 20207:00 amRNSBlock Listing Six Monthly Return
31st Dec 201912:15 pmRNSBoard Changes
27th Dec 20192:50 pmRNSManagement and Board Committee Changes
12th Dec 20192:40 pmRNSBoard and Management Changes
22nd Nov 20193:38 pmRNSResignation of a Director
20th Nov 20197:52 amRNSCorrection: Appointment of Directors
18th Nov 20193:42 pmRNSAppointment of Directors
14th Nov 20197:40 amRNSCompany Update
12th Nov 20192:52 pmRNSResignation of Director
28th Oct 20197:48 amRNSSuspension of share listing
25th Oct 20195:23 pmRNSPostponement of results and suspension of listing
23rd Oct 20194:35 pmRNSPrice Monitoring Extension
20th Sep 20194:40 pmRNSSecond Price Monitoring Extn
20th Sep 20194:35 pmRNSPrice Monitoring Extension
20th Sep 20194:15 pmRNSPostponement of Results
22nd Aug 20194:35 pmRNSPrice Monitoring Extension
16th Aug 20197:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.